GlaxoSmithKline CEO optimistic Covid-19 vaccine widely available in 2021

GSK is contributing adjuvants, efficacy boosters that play a vital role in many vaccines, in several development alliances for potential future vaccines against the novel coronavirus that has claimed more than a million lives globally.

from Hindustan Times - world https://bit.ly/3n4dHha
https://ift.tt/2zbki14